| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 11 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Medical preparations | |
| #5 | Analysing materials | |
| #6 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wakita Takaji | 11 |
| #2 | Date Tomoko | 4 |
| #3 | Nakamura Noriko | 4 |
| #4 | Akazawa Daisuke | 3 |
| #5 | Kato Takanobu | 3 |
| #6 | Takahashi Hitoshi | 2 |
| #7 | Suzuki Tetsuro | 2 |
| #8 | Miyamoto Michiko | 2 |
| #9 | Tanabe Jun-Ichi | 2 |
| #10 | Sone Saburo | 2 |
| Publication | Filing date | Title |
|---|---|---|
| US2014286995A1 | Nucleic acid construct comprising nucleic acid derived from genome of hepatitis C virus of genotype 3a | |
| US2014302092A1 | Mutant replicon derived from genome of hepatitis C virus J6CF strain | |
| US2010278865A1 | Production and use of epitope-tagged hepatitis c virus particle | |
| US2009176200A1 | Modified human hepatitis C virus genomic RNA that can be autonomously replicated |